方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| PRISMA清单：系统评价和荟萃分析报告标准× | Cochrane偏倚风险工具2.0用于随机对照试验× | |
|---|---|---|
| 领域 | 研究方法论 | 研究方法论 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2021 (original 2009) | 2019 |
| 提出者≠ | Page et al. (PRISMA Group) | Jonathan Sterne, Julian Higgins (Cochrane Collaboration) |
| 类型≠ | Systematic review author reporting checklist | Clinician-rated / Research team assessment |
| 开创性文献≠ | Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. DOI ↗ | Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. DOI ↗ |
| 别名 | PRISMA, PRISMA 2020 | RoB 2.0, RoB 2 |
| 相关 | 4 | 4 |
| 摘要≠ | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility. | RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias. |
| ScholarGate数据集 ↗ |
|
|